New Delhi, 19 September, 2023: As per the Globocan data 2020, in India, Breast Cancer accounted for 13.5% (178361) of all cancer cases and 10.6% (90408) of all deaths.This elevates the importance of early breast cancer detection in improving survival rates. As a dominant player, FUJIFILM India feels that it is its social responsibility to promote awareness regarding the early detection of breast cancer and empower healthcare professionals with the best technologies to serve the society. The ‘Together Against Breast Cancer’ conference from 15th to 17th September 2023 was organized in Goa, was organized to support this mission.
Ms. Sonali Bendre, the Brand Ambassador for breast cancer screening advocacy of FUJIFILM India who attended the event as the Guest of Honor said, “Being a cancer survivor, it fills me with joy to see the hardwork that healthcare professionals and healthcare companies like FUJIFILM India are doing to support the cause of early diagnosis of Breast Cancer”.
The three-day conference was accelerated with information, awareness, and a shared commitment to making a positive impact on women health and early detection. This prestigious event brought together luminaries from the medical field, featuring esteemed doctors hailing from prominent cities such as Mumbai, Delhi, Hyderabad, Bangalore, Kolkata, Cochin, and beyond. It was a remarkable platform for the collective exchange of wisdom, leaving attendees inspired and armed with knowledge to infuse hope into their patients. The expert sessions delved into an array of vital topics, such as empowering young women against Breast Cancer, demystifying Stereotactic Breast Biopsy, harnessing the potential of Tomosynthesis, pioneering advancements in CEDM (Contrast-Enhanced Digital Mammography), navigating the learning curves in mammography with cutting-edge technology, and celebrating the remarkable success of Mammo in rural villages on the periphery.
Reflecting on this effort, Mr. Koji Wada, the Managing Director of FUJIFILM India said “At FUJIFILM India, our unwavering commitment to women's health is exemplified by the technologies we bring and the advocacy we do for early diagnosis. The installation of 125 AMULET Innovality digital mammography machines across India are a testament to our dedication to enhance healthcare infrastructure for the early detection of breast cancer. However, I strongly feel that 125 is just a milestone in this journey and we will be expanding our installation base with a very fast pace in the near future. Beyond our advancements in healthcare technology, our 'Together Against Breast Cancer' Conference is proudly celebrating its 3rd edition, reinforcing our commitment to raising awareness. We firmly believe that improving access to technology and increasing awareness are pivotal steps toward fostering a healthier India."
“At FUJIFILM India, we're at the forefront of advancing breast cancer detection through cutting-edge imaging technologies. Given that early detection through digital mammography has become the cornerstone in our fight against breast cancer, this milestone is evidence that we were rightly able to instill hope that early detection can save lives. We are working to pioneer cutting-edge imaging technologies and this achievement underscores our commitment to enhancing early breast cancer detection, offering the finest examinations, and delivering superior imaging quality across India,” said Mr. Chander Shekhar Sibal, HOD & Vice President, Healthcare Business at FUJIFILM India.
AMULET Innovality boasts a remarkably swift ‘image capture interval’ of a mere 15 seconds, all while producing clear images with minimal X-ray dosage. Furthermore, its image analysis technology dynamically adapts the X-ray scan according to individual breast types, truly embodying its name ‘AMULET’ – always protecting women's health and allowing them to maintain their true, lively, and beautiful selves. By harnessing innovations in imaging technology, FUJIFILM India aims to encourage women from diverse backgrounds to prioritize their well-being and eliminate the stigma associated with curable cancers.